Kordasiewicz Holly B.'s Form 4 filing
Ionis Pharmaceuticals Inc (IONS) · filed Jun 16, 2026
- Accession no.
- 0000874015-26-000208
- Filed
- Jun 16, 2026
- Trade date
- Jun 12, 2026
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 6 non-derivative transactions and 4 derivative transactions. Open-market sales total $4.47M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Kordasiewicz Holly B.CIK 0002102721 | Officer (EVP, Chief Development Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 12, 2026 | Common Stock | MOption exerciseAcquired | +7,951 | $60.89 | +$484,136.39 | 30,409 | Direct | |
| Jun 12, 2026 | Common Stock | MOption exerciseAcquired | +21,000 | $60.89 | +$1,278,690 | 51,409 | Direct | |
| Jun 12, 2026 | Common Stock | MOption exerciseAcquired | +12,000 | $32.60 | +$391,200 | 63,409 | Direct | |
| Jun 12, 2026 | Common Stock | MOption exerciseAcquired | +19,895 | $56.78 | +$1,129,638.1 | 83,304 | Direct | |
| Jun 12, 2026 | Common Stock | SSaleDisposed | −41,004 | $73.09 | −$2,996,982.36 | 42,300 | Direct | |
| Jun 12, 2026 | Common Stock | SSaleDisposed | −19,842 | $74.05 | −$1,469,300.1 | 22,458 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 12, 2026 | Common Stock | MOption exerciseDisposed | −12,000 | $0.00 | $0 | 0 | Direct | |
| Jun 12, 2026 | Common Stock | MOption exerciseDisposed | −19,895 | $0.00 | $0 | 0 | Direct | |
| Jun 12, 2026 | Common Stock | MOption exerciseDisposed | −7,951 | $0.00 | $0 | 21,000 | Direct | |
| Jun 12, 2026 | Common Stock | MOption exerciseDisposed | −21,000 | $0.00 | $0 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.